Sukhi Thethy
Comptroller/Controller/Auditor presso CHINOOK THERAPEUTICS, INC.
Posizioni attive di Sukhi Thethy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Storia della carriera di Sukhi Thethy
Precedenti posizioni note di Sukhi Thethy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Formazione di Sukhi Thethy
| San Jose State University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Comptroller/Controller/Auditor | 2 |
| Graduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Borsa valori
- Insiders
- Sukhi Thethy
- Esperienza
